Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults

Journal of General Internal Medicine

Volumn 29, Issue 4, 2014, Pages 579-586

  Michaelidis, Constantinos I ^a   Zimmerman, Richard K ^a   Nowalk, Mary Patricia ^a   Fine, Michael J ^a,b   Smith, Kenneth J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

antibiotics; cost effectiveness; procalcitonin; respiratory tract infection

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; ANTIINFECTIVE AGENT; CALCITONIN; PROTEIN PRECURSOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE SYSTEM; HUMAN; OUTPATIENT CARE; PATIENT CARE; PHYSICIAN; PRESCRIPTION; QUALITY ADJUSTED LIFE YEAR; RESPIRATORY TRACT INFECTION; SENSITIVITY ANALYSIS; ACUTE DISEASE; ADULT; AMBULATORY CARE; ANIMAL; CHILD; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMIC MODEL; ECONOMICS; PROCEDURES; RESPIRATORY TRACT INFECTIONS;

ACUTE DISEASE; ADULT; AMBULATORY CARE; ANIMALS; ANTI-BACTERIAL AGENTS; CALCITONIN; CHILD; COHORT STUDIES; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; HUMANS; MODELS, ECONOMIC; PROTEIN PRECURSORS; RESPIRATORY TRACT INFECTIONS;

EID: 84898601023     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2679-7     Document Type: Article

References (32)

1. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758-66.
2. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278(11):901-4.
3. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis. 2001;33(5):757-62.
4. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Shaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J. 1996;9(8):1590-5.
5. Steinman MA, Landefield CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289(6):719-25.
6. Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis (review). Cochrane Database Syst Rev. 2010:CD000247.
7. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis (review). Cochrane Database Syst Rev. 2012:CD000245.
8. Ahovuo-Saloranta A, Rautakorpi UM, Borisenko OV, Liira H, Williams JW, Mäkelä M. Antibiotics for acute maxillary sinusitis (review). Cochrane Database Syst Rev. 2011:CD000243.
9. Goosens H, Ferech M, Stichele RB, Elseviers S. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-87.
10. van de Sande-Bruinsma N, Grundman J, Verloo D, et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis. 2008;14(11):1722-30.
11. The Interagency Task Force on Antimicrobial Resistance. A public health action plan to combat antimicrobial resistance: 2012 update. Available at: www.cdc.gov/drugresistance/actionplan/actionplan.html. Accessed October 10, 2013.
12. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2009:CD003539.
13. Goosens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol. 2006;62(5):373-9.
14. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJJ Diagnostic value of C reactive protein in infections of the lower respiratory tract: a systematic review. BMJ. 2005;331(757):26.
15. Gonzales R, Aagaard EM, Camargo CA, et al. C-reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. J Emerg Med. 2011;41(1):1-7.
16. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15); 1322-31.
17. Briel M, Schuetz P, Mueller B, et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008;168(18): 2000-7.
18. Burkhardt O, Ewig S, Haagen U, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010;36(3): 601-7.
19. Mainous AG, Hueston WJ. The cost of antibiotics in treating upper respiratory tract infections in a Medicaid population. Arch Fam Med. 1998;7(Jan/Feb):45-9.
20. Centers for Medicare & Medicaid Services. New Clinical Laboratory Fee Schedule Test Codes. Procalcitonin. Available at: www.cms.gov/Medicare/ Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Downloads/ CY2011-CLFS-New-Test-Codes.pdf. Accessed October 10, 2013.
21. Gonzales R, Corbett KK, Wong S, et al. "Get Smart Colorado," Impact of a mass media campaign to improve community antibiotic use. Med Care. 2008;46(6):597-605.
22. Oppong R, Billingsley K, Nuttall J, Hood K, Smith RD, Cost J. The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries. Eur J Health Econ. 2013;14(2):197-209.
23. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analysis: using national measures to create condition-specific values. Med Care. 1998;36(6):778-92.
24. Smith KJ, Wateska A, Nowalk MP, Raymund M, Lee BY, Zimmerman RK, Fine MJ. Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia. J Gen Intern Med. 2013;28(9):1157-64.
25. Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol. 2011; December(9):894-6.
26. Phelps T. Bud/drug resistance: sometimes less is more. Med Care. 1989;27(2): 194-203.
27. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med. 2012;172(9):715-22.
28. Annual Salary, Physician - Internal Medicine. Available at www1.salary.com/Physician-Infectious-Disease-Salary.html. Accessed October 10, 2013.
29. The Pew Charitable Trusts Health Initiative. Record-high antibiotic sales for meat and poultry production. Available at: www.pewhealth.org/other- resource/record-high-antibiotic-sales-for-meat-and-poultry-production- 85899449119. Accessed October 10, 2013.
30. Wise R, Hart T, Cars O, et al. Antimicrobial resistance is a major threat to public health. BMJ. 1998;September 5(317):609-10.
31. Hersh AL, Shapiro DJ, Pavia AT, Shah S. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011;128(6):1053-61.
32. Hersh AL, Shapiro DJ, Hicks LA. Antibiotic prescribing in ambulatory care in the United States: estimates from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (NAMCS/HAMCS). Abstract, 2012 IDWeek Conference.